Trials / Active Not Recruiting
Active Not RecruitingNCT06168812
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Sulfonylurea Safety and Effectiveness (SUSS) for Patients With Hyperglycemia and Pancreatic Ductal Adenocarcinoma: A Pragmatic Clinical Trial and Accompanying Retrospective Revie
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.
Conditions
- Pancreatic Cancer
- Pancreatic Carcinoma
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Cancer Metastatic
- Metastatic Pancreatic Cancer
- Metastatic Pancreatic Ductal Adenocarcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glipizide | The therapeutic intervention in this study involves the sulfonylurea glipizide in ER formulation. |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2026-12-05
- Completion
- 2026-12-05
- First posted
- 2023-12-13
- Last updated
- 2026-01-15
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06168812. Inclusion in this directory is not an endorsement.